Skip to content
ProteinQ2100344· pop 7· linked from 22 articles

Podoplanin

Sign in to save

Also known as Aggrus, hT1alpha-2, hT1alpha-1, glycoprotein 36, PA2.26 antigen, T1-alpha, PDPN protein, human

PDPN, i.e., podoplanin, is a small glycoprotein located on the surface membranes of various cell types. While termed PDPN in humans, it is often named: a) OTS-8, gp38, aggrus, antigen PA2.26, or RANDAM-2 (i.e., retinoic acid-induced neuronal differentiated-associated molecule-2) in mice; b) T1α protein or E11 antigen in rats; c) aggrus or gp40 in canines; and d) aggrus in hamsters and cows. Human PDPN is encoded by the PDPN gene located on the "p", i.e., short, arm of chromosome 1, region 3, band 1 (location notated as 1p36.21; see Gene nomenclature). This gene directs the formation of PDPN me

Protein · UniProt

Podoplanin

Gene
PDPN
Organism
Homo sapiens (Human)
Length
162 aa
Molecular mass
16,698 Da
Evidence
1: Evidence at protein level

Mediates effects on cell migration and adhesion through its different partners. During development plays a role in blood and lymphatic vessels separation by binding CLEC1B, triggering CLEC1B activation in platelets and leading to platelet activation and/or aggregation (PubMed:14522983, PubMed:15231832, PubMed:17222411, PubMed:17616532, PubMed:18215137). Interaction with CD9, on the contrary, attenuates platelet aggregation induced by PDPN (PubMed:18541721). Through MSN or EZR interaction promotes epithelial-mesenchymal transition (EMT) leading to ERZ phosphorylation and triggering RHOA acti…

3D-structureAlternative splicingCell junctionCell membraneCell projectionCell shapeCytoplasmDevelopmental protein
View on UniProt →

Swiss-Prot (reviewed) · via UniProt

Clinical Trials

19 registered

via ClinicalTrials.gov

Wikidata facts

Instance of
protein
Show 3 more facts
cell component
filopodium
found in taxon
Homo sapiens
Sources (5)

via Wikidata · CC0

~34 min read

Encyclopedic overview

21 sections
Contents
  • Tissues distribution
  • Structure
  • Activation of CLEC-2
  • Function and clinical significance
  • Platelet activation
  • Platelet formation
  • Hair follicle growth
  • Development of blood vessels, lymphatic vessels, and the heart
  • Development of the lung
  • Kidney function
  • Allergic contact dermatitis
  • Regeneration of the liver after hepatectomy
  • Repair myocardial infarction
  • Atherosclerosis
  • Ischemia/reperfusion tissue damage
  • Deep vein thrombosis
  • Cancer-associated venous thromboembolisms
  • Cancer
  • Inhibitors
  • References
  • External links

PDPN, i.e., podoplanin, is a small glycoprotein located on the surface membranes of various cell types. While termed PDPN in humans, it is often named: a) OTS-8, gp38, aggrus, antigen PA2.26, or RANDAM-2 (i.e., retinoic acid-induced neuronal differentiated-associated molecule-2) in mice; b) T1α protein or E11 antigen in rats; c) aggrus or gp40 in canines; and d) aggrus in hamsters and cows. Human PDPN is encoded by the PDPN gene located on the "p", i.e., short, arm of chromosome 1, region 3, band 1 (location notated as 1p36.21; see Gene nomenclature). This gene directs the formation of PDPN messenger RNA (i.e., mRNA) which in turn directs formation of the PDPN glycoprotein. Here, the term PDPN is used for the non-human as well as human glycoprotein, PDPN is used for the human gene, and Pdpn is used for the animal gene.

Studies to date have suggested that PDPN acts to promote or inhibit a wide range of physiological and pathological reactions in rodents and, in a few studies, humans. However, almost all of these studies are preliminary and require far larger follow-up studies to determine if regulating PDPN levels could be used in humans to treat the various PDPN-regulated functional responses and PDPD-induced disorders. Indeed, studies have not yet determined if the promotion or inhibition of PDPN actions can be used safely in humans.

Excerpted from Wikipedia’s “Podoplanin” article, available under the CC BY-SA 4.0 licence.

Available in 7 languages

via Wikidata sitelinks · CC0